P

Inventor

SUN SHAOYI

CA49 patents
⚠️ This page may combine multiple inventors who share the name “SUN SHAOYI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

XENON PHARMACEUTICALS INC

22 patents
US7335658B2Feb 26, 2008

Pyridazine derivatives and their use as therapeutic agents

XENON PHARMACEUTICALS INC59 citations97
US8030488B2Oct 4, 2011

Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents

XENON PHARMACEUTICALS INC34 citations92
US7767677B2Aug 3, 2010

Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

XENON PHARMACEUTICALS INC34 citations92
US7700641B2Apr 20, 2010

Spiro-oxindole compounds and their uses as therapeutic agents

XENON PHARMACEUTICALS INC39 citations92
US7592343B2Sep 22, 2009

Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors

XENON PHARMACEUTICALS INC22 citations92
US7456180B2Nov 25, 2008

Piperazine derivatives and their use as therapeutic agents

XENON PHARMACEUTICALS INC24 citations92
US9630929B2Apr 25, 2017

Benzenesulfonamide compounds and their use as therapeutic agents

XENON PHARMACEUTICALS INC11 citations84
US7547698B2Jun 16, 2009

Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)

XENON PHARMACEUTICALS INC18 citations84
US8916580B2Dec 23, 2014

Spiro-oxindole compounds and their use as therapeutic agents

XENON PHARMACEUTICALS INC4 citations83
US7919484B2Apr 5, 2011

Combination therapy

XENON PHARMACEUTICALS INC10 citations83
US9487535B2Nov 8, 2016

Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents

XENON PHARMACEUTICALS INC5 citations73
US7763618B2Jul 27, 2010

Pyridyl derivatives and their use as therapeutic agents

XENON PHARMACEUTICALS INC2 citations62
US7754711B2Jul 13, 2010

Pyridazine derivatives and their use as therapeutic agents

XENON PHARMACEUTICALS INC2 citations62
US11639351B2May 2, 2023

Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents

XENON PHARMACEUTICALS INC0 citations61
US10981905B2Apr 20, 2021

Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents

XENON PHARMACEUTICALS INC1 citations61
US9458178B2Oct 4, 2016

Spiro-oxindole compounds and their use as therapeutic agents

XENON PHARMACEUTICALS INC1 citations61
US8026360B2Sep 27, 2011

Substituted pyridazines as stearoyl-CoA desaturase inhibitors

XENON PHARMACEUTICALS INC3 citations61
US7919496B2Apr 5, 2011

Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes

XENON PHARMACEUTICALS INC1 citations52
US8383628B2Feb 26, 2013

Pyridyl derivatives and their use as therapeutic agents

XENON PHARMACEUTICALS INC0 citations51
US7605161B2Oct 20, 2009

Pyridyl derivatives and their use as therapeutic agents

XENON PHARMACEUTICALS INC0 citations51
US12054486B2Aug 6, 2024

Pyridine derivatives and their use as sodium channel activators

XENON PHARMACEUTICALS INC0 citations44
US7951805B2May 31, 2011

Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase

XENON PHARMACEUTICALS INC0 citations41

GENENTECH INC

12 patents

DALES NATALIE

6 patents

CHAFEEV MIKHAIL

5 patents

NOVARTIS AG

1 patent

FU JIANMIN

1 patent

CHOWDHURY SULTAN

1 patent

ABREO MELWYN

1 patent